Sight SciencesSGHT +0.18%71 Days Inventory is 247.82 as of Mar. 2026, which is 83% above its 10-year median of 135.15. GuruFocus rates SGHT with a GF Score™ of 71/100 and a GF Value™ of $4.49 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Sight Sciences ranks worse than 66.28% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Sight Sciences's Average Total Inventories for the
three
months ended in Mar. 2026 was $7.39 Mil. Sight Sciences's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $2.72 Mil.
Hence, Sight Sciences's Days Inventory for the
three
months ended in Mar. 2026 was 247.82.
The historical rank and industry rank for Sight Sciences's Days Inventory or its related term are showing as below:
SGHT'
s Days Inventory Range Over the Past 10 Years
Min: 75.87 Med: 135.15 Max: 240.42
Current: 230.73
During the past 8 years, Sight Sciences's highest Days Inventory was 240.42. The lowest was 75.87. And the median was 135.15.
SGHT's Days Inventory is ranked worse than 66.28% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SGHT: 230.73
Sight Sciences's Days Inventory
increased
from Mar. 2025 (229.26) to Mar. 2026 (247.82).
It might indicate that Sight Sciences's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sight Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sight Sciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.38.
Sight Sciences (NAS:SGHT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sight Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sight Sciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sight Sciences Days Inventory Related Terms
Sight Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Sight Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGHT vs SENS, LAB, TMCI: Days Inventory Comparison
For the Medical Devices subindustry, Sight Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sight Sciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sight Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sight Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sight Sciences (SGHT) has a Days Inventory of 247.82 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sight Sciences and its competitors. This is 83% above median its historical median of 135.15. Over the past decade, Sight Sciences' Days Inventory has ranged from 75.87 to 240.42. According to the industry distribution chart, Sight Sciences ranks #521 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 66.3%.
Is Sight Sciences' Days Inventory too high?
Sight Sciences' current Days Inventory of 247.82 is 83% above median its 10-year median of 135.15. Over the past 10 years, this metric has ranged from a low of 75.87 to a high of 240.42. The Medical Devices & Instruments industry median Days Inventory is 179.60. Sight Sciences' value of 247.82 is 38% above this industry median. Based on the distribution chart, Sight Sciences ranks #521 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sight Sciences has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sight Sciences' Days Inventory compare to SENS and LAB?
According to the Medical Devices & Instruments industry distribution chart, Sight Sciences ranks #521 out of 786 companies for Days Inventory. This places Sight Sciences in the lower half of its industry. The industry median Days Inventory is 179.60. Sight Sciences' value of 247.82 is 38% above this benchmark. Historically, Sight Sciences' own Days Inventory has ranged from 75.87 to 240.42 over the past decade. While the company's 10-year median is 135.15 vs. the industry median of 179.60, Sight Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sight Sciences's current Days Inventory of 247.82 is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sight Sciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sight Sciences's current Days Inventory is 247.82, which is 83% above median its own 10-year median of 135.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sight Sciences stock overvalued right now?
Based on GuruFocus' analysis, Sight Sciences (SGHT) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.49, compared to a current price of $5.68 — trading 26.5% above its estimated fair value. The current Days Inventory is 247.82, which is 83% above median its 10-year median of 135.15 and 38% above the Medical Devices & Instruments industry median of 179.60. Sight Sciences' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sight Sciences (SGHT), the current Days Inventory is 247.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sight Sciences (SGHT) Overvalued in 2026?
Based on GuruFocus' analysis, Sight Sciences stock appears to be overvalued.
The current stock price of $5.68 is trading 26.5% above its estimated GF Value™ of $4.49.
GuruFocus considers Sight Sciences to be Modestly Overvalued.
Key valuation signals for SGHT:
Days Inventory: 247.82 (83% above median its 10-year median of 135.15)
GF Value™: $4.49 vs. price of $5.68 (26.5% above fair value)
Industry Position: 38% above the Medical Devices & Instruments median (#521 of 786)
No single metric tells the full story. See the SGHT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
71GF Score
Get the complete analysis for SGHT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGHT has been successfully added to your 
